Example: Heart Attack

Search clinical trials for: 11-hydroxyprogesterone

Total 42 results

NCT04183452

Recruiting

17-OHPC in Pregnancy: IM vs SC Routes

Conditions: Preterm Birth
NCT04077853

Recruiting

Progesterone in Expectantly Managed Early-onset Preeclampsia

Conditions: Preeclampsia
NCT03779438

Recruiting

17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa

Conditions: Placenta Previa
NCT03779451

Recruiting

Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa

Conditions: Placenta Previa
NCT03548246

Not yet recruiting

Androgen Reduction in Congenital Adrenal Hyperplasia

Conditions: Congenital Adrenal Hyperplasia
NCT03433040

Active, not recruiting

17OHP-C Dosing Among Obese Pregnant Women

Conditions: Premature Birth; Absorption; Chemicals
NCT03297216

Active, not recruiting

Improving Pregnancy Outcomes With Progesterone

Conditions: Pre-term Birth; HIV-1-infection
NCT03292731

Recruiting

Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth

Conditions: Preterm Birth
NCT03257462

Completed

Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia

Conditions: Congenital Adrenal Hyperplasia; CAH - Congenital Adrenal Hyperplasia
NCT03174691

Completed

Early Luteal Progesterone Profile in IVF Patients Triggered With hCG

Conditions: Infertility
NCT03130504

Completed

Intramuscular Hydroxyprogesterone Caproate and Placenta Previa

Conditions: Preterm Labor
NCT02989025

Recruiting

Progesterone to Enhance the Efficacy and Success of Expectantly Managed Preterm Severe/Superimposed Preeclampsia

Conditions: Pregnancy
NCT02940522

Completed

Comparing Bioavailability When Preservative-free Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) is Administered as an Intramuscular Manual Injection or as a Subcutaneous Injection Using an Auto-injector in Healthy Post-menopausal Women

Conditions: Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women
NCT02937766

Terminated

Study Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) When Administered Via Subcutaneous Auto-injector vs Intramuscular Injection Via Needle and Syringe in Healthy Post-menopausal Women

Conditions: Assessing Injection Pain of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) in Healthy Post-menopausal Women
NCT02913495

Recruiting

Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth

Conditions: Premature Birth
NCT02818660

Unknown status

Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests

Conditions: Adrenal Insufficiency
NCT02304237

Unknown status

Vaginal Compared With Intramuscular Progesterone for Prevention of Preterm Birth in High Risk Pregnant Women

Conditions: Premature Birth
NCT02173210

Completed

Precision Medicine for Preterm Birth

Conditions: Premature Birth
NCT01899846

Completed

Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood

Conditions: Pregnancy
NCT01608451

Active, not recruiting

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Conditions: Locally Advanced Breast Cancer and Large Operable Breast Cancer
NCT01501890

Withdrawn

Progesterone for First Trimester Vaginal Bleeding

Conditions: Threatened Abortion; Pre-Eclampsia; Abruptio Placentae; Fetal Growth Retardation; Premature Birth
NCT01317225

Unknown status

Prevention of Preterm Labor in Patients With a Previous Episode of Threatened Preterm Labor With Progesterone

Conditions: Preterm Birth; Obstetric Labor, Premature
NCT01178788

Completed

Progestagens for the Tertiary Prophylaxis of Preterm Delivery

Conditions: Preterm Delivery; Neonatal Complications
NCT01146990

Recruiting

A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

Conditions: Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial
NCT01119963

Completed

Progesterone (17P, Makena®) for Prolongation of Pregnancy in Women With Preterm Rupture of the Membranes (PROM)

Conditions: Preterm Delivery
NCT01050647

Completed

Progesterone for the Management of Preterm, Premature Rupture of the Membranes: A Randomized Controlled Trial.

Conditions: Pregnancy Complications
NCT01004029

Completed

Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery

Conditions: Preterm Birth
NCT00809939

Unknown status

17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor

Conditions: Pregnancy
NCT00694967

Terminated

A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix

Conditions: Mid Trimester Cervical Shortening
NCT00579553

Completed

Comparing IM vs. Vaginal Progesterone for Pre-term Birth

Conditions: Infant, Premature; Premature Birth
NCT00577122

Completed

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

Conditions: Estrogen Receptor-negative Breast Cancer; Progesterone Receptor-negative Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer
NCT00457886

Completed

Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery

Conditions: Preterm Delivery
NCT00439374

Terminated

RCT of Progesterone to Prevent Preterm Birth in Nulliparous Women With a Short Cervix

Conditions: Preterm Delivery; Cervical Length
NCT00409825

Completed

Study of Pharmacology of 17-OHPC in Pregnancy

Conditions: Pregnancy
NCT00331695

Completed

Efficacy of 17 Alpha-hydroxyprogesterones Caproate for the Prevention of Preterm Delivery

Conditions: Preterm Delivery
NCT00163020

Completed

17OHP for Reduction of Neonatal Morbidity Due to Preterm Birth (PTB) in Twin and Triplet Pregnancies

Conditions: Preterm Birth
NCT00156000

Withdrawn

fFN & E3 in the Prediction of PTB in Women With Twin Pregnancies Receiving 17OHP or Placebo

Conditions: Preterm Delivery; Preterm Birth
NCT00141908

Completed

Prevention of Preterm Delivery in Twin Pregnancies by 17 Alpha-hydroxyprogesterone Caproate

Conditions: Preterm Delivery
NCT00135902

Completed

Omega-3 Fatty Acid Supplementation to Prevent Preterm Birth in High Risk Pregnancies

Conditions: Preterm Birth
NCT00123669

Completed

Primary Progesterone Therapy for Operable Breast Cancer

Conditions: Breast Neoplasms
NCT00120640

Withdrawn

Treatment of Preterm Labor With 17 Alpha-hydroxyprogesterone Caproate

Conditions: Premature Birth; Premature Labor
NCT00099164

Completed

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

Conditions: Preterm Birth; Pregnancy; Multifetal

Search clinical trials for: 11-hydroxyprogesterone

Recent CRA jobs

Start-up CRA, Ukraine

Remote Site Monitor, Ukraine

Accounting Coordinator (Cambridge)

Associate Treasury Analyst (Cambridge)

Sr Safety Reporting Admin

Recruitment Coordinator (6-month)

CRA (Level I or II)

Clinical Trial Coord (Previuos called PA)

CRA (Level to be defined)

Assoc Biostatistician- Wayne PA